Chronic inflammatory demyelinating polyradiculoneuropathy
Showing 9976 - 10000 of >10,000
Pneumonia, Viral Trial in Reus, Barcelona, Madrid (radiation, drug, device)
Recruiting
- Pneumonia, Viral
- Low-dose radiotherapy
- +7 more
-
Reus, Tarragona, Spain
- +2 more
Jul 29, 2021
Exposure to Pollution, Glucocorticoid Resistance Trial in Vancouver (Placebo, Budesonide, Filtered Air)
Recruiting
- Exposure to Pollution
- Glucocorticoid Resistance
- Placebo
- +3 more
-
Vancouver, British Columbia, CanadaUniversity of British Columbia
Oct 29, 2021
Pelvic Inflammatory Disease Trial in Karachi (Fuke Qianjin capsule, metronidazole tablets + doxycycline hyclate tablets)
Recruiting
- Pelvic Inflammatory Disease
- Fuke Qianjin capsule
- metronidazole tablets + doxycycline hyclate tablets
-
Karachi, PakistanCenter for Bioequivalence Studies and Clinical Research (CBSCR),
Oct 5, 2021
Manganese-Enhanced Magnetic Resonance Imaging in Ischaemic,
Recruiting
- Myocarditis
- +2 more
- Cardiac MRI
-
Edinburgh, United KingdomRoyal Infirmary of Edinburgh
Sep 28, 2021
The Significance of Circulating Microvesicles in Pulmonary
Not yet recruiting
- Pulmonary Hypertension Due to Chronic
- +3 more
- Catheterization
-
Strasbourg, FranceHôpitaux Universitaire de Strasbourg - Service Pneumologie - cen
Jun 21, 2022
Gaucher Disease, Type 1, Gaucher Disease, Type 3 Trial in Beijing (Low-dose CAN103, High-dose CAN103)
Recruiting
- Gaucher Disease, Type 1
- Gaucher Disease, Type 3
- Low-dose CAN103
- High-dose CAN103
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 25, 2022
Hypertension Trial in Konya (The Effect of the Mobile Application)
Completed
- Hypertension
- The Effect of the Mobile Application
-
Konya, TurkeyAlev YILDIRIM KESKİN
Apr 18, 2022
COVID 19, Immunomediated Inflammatory Disease in Treatment With Biological Agents and / or Jak Inhibitors Trial
Withdrawn
- COVID 19
- Immunomediated Inflammatory Disease in Treatment With Biological Agents and / or Jak Inhibitors
- Hidroxicloroquina
- Control group
- (no location specified)
Sep 8, 2021
Sphingomyelin Lipidosis Trial (olipudase alfa (GZ402665))
Approved for marketing
- Sphingomyelin Lipidosis
- olipudase alfa (GZ402665)
- (no location specified)
Sep 15, 2022
Water Sorption Capacity and Composition of Bronchial Fluids of
Recruiting
- COPD
- Healthy
-
Essen, NRW, GermanyKliniken Essen-Mitte, Evang. Huyssens-Stiftung/Knappschaft gGmbH
Sep 13, 2021
Chronic Pain Trial in Almería (Experimental: monopolar dielectric diathermy and supervised therapeutic exercise, Active
Completed
- Chronic Pain
- Experimental: monopolar dielectric diathermy and supervised therapeutic exercise
- Active Comparator: Supervised therapeutic exercise
-
Almería, SpainAdelaida María Castro-Sánchez
Jul 20, 2022
Type 2 Diabetes, Insomnia, Sleep Disorder Trial in Boston (Suvorexant, Placebo)
Active, not recruiting
- Type 2 Diabetes Mellitus
- +3 more
- Suvorexant
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital
Aug 31, 2021
Cognitive Decline Trial (Direct Current Transcranial Stimulation - tDCS, Sham Intervention)
Unknown status
- Cognitive Decline
- Direct Current Transcranial Stimulation - tDCS
- Sham Intervention
- (no location specified)
Jun 14, 2021
Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome Trial in Maywood (Atorvastatin, Methotrexate,
Withdrawn
- Acute Myeloid Leukemia
- +2 more
- Atorvastatin
- +2 more
-
Maywood, IllinoisLoyola University Medical Center
Apr 23, 2021
Endoscopic Antral Myotomy as a Novel Weight Loss Procedure
Not yet recruiting
- Obesity
- +4 more
- PSAM Treatment Patients
-
Boston, MassachusettsBrigham and Women's Hospital
Jan 25, 2023
COPD (COPD) Trial in Guangzhou (Autologuos transplantation of bronchial basal cells)
Recruiting
- Chronic Obstructive Pulmonary Disease (COPD)
- Autologuos transplantation of bronchial basal cells
-
Guangzhou, Guangdong, ChinaGuangzhou Institute of Respiratory Disease, The First Affiliated
Oct 25, 2022
French Version of POMI Scale
Completed
- Chronic Pain
- Opioid Misuse
- (no location specified)
Feb 28, 2022
Gluten-Free Diet and Affecting Factors in Celiac Disease
Completed
- Celiac Disease in Adolescents
- Gluten-Free Diet in the Covid-19 Process
-
Bursa, TurkeyBursa Uludağ University
Jul 24, 2022
Nasal Polyposis Trial in Worldwide (Benralizumab 30 mg, Matched )
Recruiting
- Nasal Polyposis
- Benralizumab 30 mg
- Matched placebo
-
Fresno, California
- +141 more
Aug 17, 2022
Anemia; Hemodialysis Dependent Chronic Kidney Disease Trial in Japan (MT-6548)
Completed
- Anemia; Hemodialysis Dependent Chronic Kidney Disease
-
Aichi, Japan
- +15 more
Jul 26, 2021
Acute Kidney Injury KDIGO 3, Continuous Renal Replacement Therapy Initiated by the Clinician in Charge Without Emergency,
Recruiting
- Acute Kidney Injury KDIGO 3
- +2 more
- Continuous renal replacement therapy
- Control group
-
Bron, France
- +1 more
Apr 21, 2022
Chronic Pain Trial in Los Angeles (painTRAINER®, PICO G2 4k)
Recruiting
- Chronic Pain
- painTRAINER®
- PICO G2 4k
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Jul 18, 2022
Adenomyosis Trial in France (11.25mg GnRH agonist, 0.1 mg GnRH agonist, 25 µg transdermal oestradiol)
Withdrawn
- Adenomyosis
- 11.25mg GnRH agonist
- +2 more
-
Angers, France
- +13 more
Nov 14, 2022
Sleep Disturbance, Fatigue, Body Weight Trial in Mecca (Kiwifruit)
Completed
- Sleep Disturbance
- +2 more
- Kiwifruit
-
Mecca, Saudi ArabiaUmm Al-Qura University
Jul 11, 2023